News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
73–108
Matches
629
Sources here
16
Companies here
16
Search results Stored financial headlines

Active search

629 matching headlines

Ticker or company: CITIMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Citigroup Adjusts Price Target on Becton Dickinson and Co. to $208 From $204, Maintains Buy Rating

Citigroup has raised its price target for Becton Dickinson and Co. (BDX) from $204 to $208, while reiterating a Buy rating on the stock. This adjustment reflects an updated outlook by the analyst firm on the medical technology company. The article also provides a …

C main company
Sharemaestro market context Trend signal active 52 weeks +48.6% · Next-week setup positive 60.8% C stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Citigroup Initiates Sibanye Stillwater at Buy With $13.50 Price Target

Citigroup has initiated coverage on Sibanye Stillwater with a "Buy" rating and set a price target of $13.50. Sibanye-Stillwater is a major producer of gold and platinum group metals, with operations in South Africa and the United States. The company's stock performance and analyst …

C main company
Sharemaestro market context Trend signal active 52 weeks +48.6% · Next-week setup positive 60.8% C stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Citigroup Adjusts PT on Huntington Ingalls Industries to $379 From $349, Keeps Buy Rating

Citigroup has increased its price target for Huntington Ingalls Industries (HII) to $379, up from $349, while maintaining a "Buy" rating on the stock. This adjustment reflects a positive outlook on the company's financial prospects and market performance.

C main company
Sharemaestro market context Trend signal active 52 weeks +48.6% · Next-week setup positive 60.8% C stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Citigroup Adjusts Price Target on Leidos Holdings to $161 From $138, Keeps Buy Rating

Citigroup has increased its price target for Leidos Holdings (LDOS) to $161 from $138, while reiterating a Buy rating on the stock. This adjustment reflects analyst confidence in the company, which specializes in engineering, technological, and scientific services across civil security, health, energy, and …

C main company
Sharemaestro market context Trend signal active 52 weeks +48.6% · Next-week setup positive 60.8% C stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Citi Trends, Inc. $CTRN Shares Sold by Tectonic Advisors LLC

Tectonic Advisors LLC reduced its stake in Citi Trends (CTRN) by 48.4% in the second quarter, selling 23,561 shares but still holding 25,126 shares valued at $1.45 million. Despite this sale, analyst sentiment remains positive with a "Moderate Buy" consensus rating and a $73 …

CTRN main company
Sharemaestro market context Trend signal active 52 weeks +126.8% CTRN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Wasatch Advisors LP Cuts Stock Holdings in Citigroup Inc. $C

Wasatch Advisors LP reduced its stake in Citigroup Inc. by 19.6% in the second quarter, selling 11,113 shares but still holding 45,570 shares valued at $6.38 million. This comes as Citigroup reported strong quarterly earnings, exceeding analyst expectations with $3.15 per share and $24.77 …

C main company
Sharemaestro market context Trend signal active 52 weeks +48.6% · Next-week setup positive 60.8% C stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Citizens raises Pharvaris stock price target to $75 on trial progress

Citizens has increased its price target for Pharvaris B.V. to $75.00 from $74.00, maintaining a Market Outperform rating, due to ongoing trial progress. The company's stock has surged 70% in the past year, and key Phase 3 CHAPTER-3 data is expected this quarter. Pharvaris …

CFG main company
Sharemaestro market context Trend signal active 52 weeks +50.6% · Next-week setup positive 60.8% CFG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Diversified Management Inc. Trims Stock Position in Citigroup Inc. $C

Diversified Management Inc. significantly reduced its stake in Citigroup Inc. by 85.4% in the second quarter, selling over 10,000 shares. Despite this, institutional ownership remains high at 71.72%, and analysts maintain a "Moderate Buy" rating for Citigroup, with an average price target of $145.22. …

C main company
Sharemaestro market context Trend signal active 52 weeks +48.6% · Next-week setup positive 60.8% C stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Citius Oncology Expands Board with Appointment of Independent Director Jonathan Peri

Citius Oncology, a biopharmaceutical company, announced the appointment of Jonathan Peri, Ph.D., J.D., as an independent director to its Board, expanding it to nine members. Dr. Peri brings extensive leadership experience in higher education, financial services, law, and corporate governance, which is expected to …

CTOR main company CTXR main company
Sharemaestro market context Price above Trend Line 52 weeks -48.0% CTOR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

C6480247 Bond Price and Chart — FINRA:C6480247

This article provides detailed financial information for the Citigroup Global Markets Holdings Inc. 5.2% bond maturing on August 20, 2031 (FINRA:C6480247). It includes key terms such as outstanding amount, face value, coupon rate, and term to maturity, along with issuer details and various identifiers. …

C main company
Sharemaestro market context Trend signal active 52 weeks +48.6% · Next-week setup positive 60.8% C stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Citizens Financial (CFG): Capital World Investors reports 5.6% stake in common stock

Capital World Investors has filed an amended ownership report disclosing a 5.6% beneficial stake in Citizens Financial Group, Inc., amounting to 23,539,168 shares of common stock. The filing indicates that Capital World Investors holds sole voting power over 23,249,957 shares and sole dispositive power …

CFG main company
Sharemaestro market context Trend signal active 52 weeks +50.6% · Next-week setup positive 60.8% CFG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Citizens Financial Group Inc. stock underperforms Wednesday when compared to competitors despite daily gains

Citizens Financial Group Inc. (CFG) stock increased by 1.26% on Wednesday, closing at $73.91, despite a mixed trading session for the broader market. While the S&P 500 Index saw gains, the Dow Jones Industrial Average slightly declined. This marks the second consecutive day of …

CFG main company
Sharemaestro market context Trend signal active 52 weeks +50.6% · Next-week setup positive 60.8% CFG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Price to sales forward of Citizens Financial Services, Inc. – NASDAQ:CZFS

This article provides a brief overview of the "Price to sales forward" metric for Citizens Financial Services, Inc. (NASDAQ: CZFS). It presents this financial data point within the TradingView platform context, indicating its period, value, and change.

CZFS main company
Sharemaestro market context Trend signal active 52 weeks +40.6% CZFS stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Citizens, Inc. (CIA) CEO Jon Stenberg purchases 12,000 shares in open market

Citizens, Inc. CEO Jon Stenberg has purchased 12,000 shares of Class A common stock on the open market at $3.6496 per share. This transaction, filed on August 12, 2026, increased his direct holdings to 389,574 shares, with an additional 130,100 shares held indirectly through …

CIA main company
Sharemaestro market context Price below Trend Line 52 weeks -25.8% CIA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Citigroup affirms Excelerate Energy's Outperform rating after strong Q2 with raised EBITDA forecast.

Citigroup has reaffirmed its Outperform rating on Excelerate Energy following strong Q2 2026 results, which saw net income of $50.1 million and adjusted EBITDA of $120.1 million, surpassing estimates. The company raised its full-year adjusted EBITDA forecast to $490-$515 million, driven by new projects …

C main company
Sharemaestro market context Trend signal active 52 weeks +48.6% · Next-week setup positive 60.8% C stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Citigroup Inc. stock outperforms competitors on strong trading day

Citigroup Inc. stock (C) rose by 1.33% to $137.58 on Wednesday, outperforming the mixed market, with the S&P 500 Index gaining 0.26% and the Dow Jones Industrial Average falling 0.04%. This marks the fourth consecutive day of gains for the stock.

C main company
Sharemaestro market context Trend signal active 52 weeks +48.6% · Next-week setup positive 60.8% C stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Is Citigroup (C) Undervalued After Its Latest Bond Offerings?

Citigroup (C) has been active in the bond market with new bond offerings. Despite a recent slight dip in share price, its 1-year total shareholder return is strong, leading to a "Most Popular Narrative" that values the stock at $154.00, suggesting it is undervalued. …

C main company C main company CTGP34 main company C main company TRVC main company CITI main company
Sharemaestro market context Trend signal active 52 weeks +72.6% · Next-week setup positive 57.8% C stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Form 8K Citius Oncology Inc For: 12 August By Investing.com

This article announces the filing of a Form 8K by Citius Oncology Inc. on August 12, 2026. The content is brief and primarily serves as a news alert for the filing, with a focus on market data and other news. Citius Oncology Inc. (CTOR) …

CTOR main company
Sharemaestro market context Price above Trend Line 52 weeks -48.0% CTOR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Citius Oncology appoints Jonathan Peri to board of directors By Investing.com

Citius Oncology, Inc. has appointed Jonathan Peri, Ph.D., J.D., as an independent director to its board, expanding it to nine members. Peri brings 30 years of experience in higher education, financial services, law, and corporate governance. The company, a subsidiary of Citius Pharmaceuticals, Inc., …

CTOR main company
Sharemaestro market context Price above Trend Line 52 weeks -48.0% CTOR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Citius Oncology appoints Jonathan Peri to board of directors

Citius Oncology, a subsidiary of Citius Pharmaceuticals, has appointed Jonathan Peri, Ph.D., J.D., as an independent director to its board. This appointment expands the board to nine members. Peri brings extensive experience in higher education, financial services, law, and corporate governance to the role.

CTXR main company
Sharemaestro market context Price above Trend Line 52 weeks -44.0% · Next-week setup negative 40.1% CTXR stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Wedge Capital Management L L P NC Lowers Stake in Citigroup Inc. $C

Wedge Capital Management L L P NC reduced its stake in Citigroup Inc. by 6.7% in the second quarter, selling 18,194 shares and now holding 254,560 shares valued at $35.6 million. Despite this reduction, Citigroup reported strong quarterly results with higher-than-expected EPS and revenue, …

C main company
Sharemaestro market context Trend signal active 52 weeks +48.6% · Next-week setup positive 60.8% C stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Northside Capital Management LLC Reduces Holdings in Citigroup Inc. $C

Northside Capital Management LLC reduced its stake in Citigroup Inc. by 28.4% in the second quarter, selling 34,091 shares and retaining 85,841 shares valued at approximately $12.0 million. Despite this, institutional investors own a significant 71.72% of Citigroup. The company recently reported strong quarterly …

C main company
Sharemaestro market context Trend signal active 52 weeks +48.6% · Next-week setup positive 60.8% C stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Citigroup Adjusts Price Target on Howmet Aerospace to $329 From $311, Keeps Buy Rating

Citigroup has raised its price target for Howmet Aerospace (HWM) to $329 from $311, while maintaining a Buy rating on the stock. This adjustment reflects an updated outlook from the financial firm on the aerospace company's valuation. The report was published by MT Newswires …

C main company
Sharemaestro market context Trend signal active 52 weeks +48.6% · Next-week setup positive 60.8% C stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Citizens Inc. president & CEO Jon Stenberg buys $199,630 in stock

Citizens Inc. President & CEO Jon Stenberg recently purchased 50,000 shares of the company's Class A Common Stock for a total of $199,630. This transaction occurred on August 10, 2026, when the stock was trading near its 52-week low. Stenberg now directly and indirectly …

CIA main company
Sharemaestro market context Price below Trend Line 52 weeks -25.8% CIA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Citigroup Inc. Trims Wolfspeed Inc (WOLF) Stake by 78% in June 2

Citigroup Inc. significantly reduced its stake in Wolfspeed Inc (WOLF) by 78.01% on June 30, 2026, selling over 2.5 million shares at $48.25 each. This move, which leaves Citigroup with a 1.40% ownership stake, reflects a reassessment of Wolfspeed's prospects given its weak financial …

C main company
Sharemaestro market context Trend signal active 52 weeks +48.6% · Next-week setup positive 60.8% C stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Citizens, Inc. Class A Revenue Breakdown – LS:694147

This article provides a revenue breakdown for Citizens, Inc. Class A (LS:694147), detailing its top-performing segments and regional contributions. Last year, the company generated €217.52 million, with International Insurance being the primary segment, contributing €149.56 million. The United States was the largest geographical contributor, …

CIA main company
Sharemaestro market context Price below Trend Line 52 weeks -25.8% CIA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context